145 related articles for article (PubMed ID: 15234400)
1. Diminishing returns...and too many choices...the saga of pharmacologic therapy to reduce the complications of percutaneous coronary intervention.
Stadius ML
J Am Coll Cardiol; 2004 Jul; 44(1):25-7. PubMed ID: 15234400
[No Abstract] [Full Text] [Related]
2. Lack of efficacy of clopidogrel pre-treatment in the prevention of myocardial damage after elective stent implantation.
van der Heijden DJ; Westendorp IC; Riezebos RK; Kiemeneij F; Slagboom T; van der Wieken LR; Laarman GJ
J Am Coll Cardiol; 2004 Jul; 44(1):20-4. PubMed ID: 15234399
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous kissing stents (SKS) technique for treating bifurcation lesions in medium-to-large size coronary arteries.
Sharma SK; Choudhury A; Lee J; Kim MC; Fisher E; Steinheimer AM; Kini AS
Am J Cardiol; 2004 Oct; 94(7):913-7. PubMed ID: 15464676
[TBL] [Abstract][Full Text] [Related]
4. Optimal duration of eptifibatide infusion in percutaneous coronary intervention (an ESPRIT substudy).
Rebeiz AG; Dery JP; Tsiatis AA; O'shea JC; Johnson BA; Hellkamp AS; Pieper KS; Gilchrist IC; Slater J; Muhlestein JB; Joseph D; Kitt MM; Tcheng JE;
Am J Cardiol; 2004 Oct; 94(7):926-9. PubMed ID: 15464679
[TBL] [Abstract][Full Text] [Related]
5. Point-of-care assessment of platelet reactivity after clopidogrel to predict myonecrosis in patients undergoing percutaneous coronary intervention.
Mangiacapra F; Barbato E; Patti G; Gatto L; Vizzi V; Ricottini E; D'Ambrosio A; Wijns W; Di Sciascio G
JACC Cardiovasc Interv; 2010 Mar; 3(3):318-23. PubMed ID: 20298992
[TBL] [Abstract][Full Text] [Related]
6. Prognostic implications of cardiac marker elevation after percutaneous coronary intervention.
Nageh T; Sherwood RA; Thomas MR
Circulation; 2002 Mar; 105(12):e73. PubMed ID: 11914268
[No Abstract] [Full Text] [Related]
7. Prognostic implication of troponin I elevation after percutaneous coronary intervention.
Nallamothu BK; Chetcuti S; Mukherjee D; Grossman PM; Kline-Rogers E; Werns SW; Bates ER; Moscucci M
Am J Cardiol; 2003 May; 91(10):1272-4. PubMed ID: 12745120
[No Abstract] [Full Text] [Related]
8. Use of clopidogrel in the reduction of myocardial damage during percutaneous coronary intervention.
Dasgupta A; Mukherjee D
Vasc Health Risk Manag; 2009; 5(1):275-86. PubMed ID: 19436675
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of elevated troponin I after percutaneous coronary intervention.
Cantor WJ; Newby LK; Christenson RH; Tuttle RH; Hasselblad V; Armstrong PW; Moliterno DJ; Califf RM; Topol EJ; Ohman EM;
J Am Coll Cardiol; 2002 Jun; 39(11):1738-44. PubMed ID: 12039485
[TBL] [Abstract][Full Text] [Related]
10. Treatment of acute coronary syndromes.
Tahiliani N; Trivedi A; Deshmukh HG
N Engl J Med; 2002 Jan; 346(3):206-8. PubMed ID: 11797722
[No Abstract] [Full Text] [Related]
11. Effects of persistent platelet reactivity despite aspirin therapy on cardiac troponin I and creatine kinase-MB levels after elective percutaneous coronary interventions.
Gulmez O; Yildirir A; Kaynar G; Konas D; Aydinalp A; Ertan C; Ozin B; Muderrisoglu H
J Thromb Thrombolysis; 2008 Jun; 25(3):239-46. PubMed ID: 17574519
[TBL] [Abstract][Full Text] [Related]
12. For how long should treatment with clopidogrel be continued after coronary stent implantation?
Rozenman Y
J Am Coll Cardiol; 2004 Apr; 43(7):1331; author reply 1331-2. PubMed ID: 15063450
[No Abstract] [Full Text] [Related]
13. Does pre-treatment with aspirin and loading dose clopidogrel obviate the need for glycoprotein IIb/IIIa antagonists during elective coronary stenting? A focus on peri-procedural myonecrosis.
Claeys MJ; Van der Planken MG; Bosmans JM; Michiels JJ; Vertessen F; Van Der Goten P; Wuyts FL; Vrints CJ
Eur Heart J; 2005 Mar; 26(6):567-75. PubMed ID: 15618034
[TBL] [Abstract][Full Text] [Related]
14. Comparison of different cardiac markers in monitoring percutaneous coronary interventions with frequent use of stents and gpIIbIIIa-antagonists.
Mark B; Schneider S; Schiele R; Taubert G; Kilkowski C; Seidl K; Nagel D; Seiler D; Senges J; Zahn R
Z Kardiol; 2003 Dec; 92(12):1018-24. PubMed ID: 14663612
[TBL] [Abstract][Full Text] [Related]
15. Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study.
Pasceri V; Patti G; Nusca A; Pristipino C; Richichi G; Di Sciascio G;
Circulation; 2004 Aug; 110(6):674-8. PubMed ID: 15277322
[TBL] [Abstract][Full Text] [Related]
16. Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment.
Chen WH; Lee PY; Ng W; Tse HF; Lau CP
J Am Coll Cardiol; 2004 Mar; 43(6):1122-6. PubMed ID: 15028378
[TBL] [Abstract][Full Text] [Related]
17. Treatment modalities of non-ST-elevation acute coronary syndromes in the real world. Results of the prospective R.OS.A.I.-2 registry.
Registro Osservazionale Angina Instabile Investigators
Ital Heart J; 2003 Nov; 4(11):782-90. PubMed ID: 14699708
[TBL] [Abstract][Full Text] [Related]
18. Impact of final activated clotting time after transradial coronary stenting with maximal antiplatelet therapy.
Bertrand OF; Rodés-Cabau J; Rinfret S; Larose E; Bagur R; Proulx G; Gleeton O; Costerousse O; De Larochellière R; Roy L
Am J Cardiol; 2009 Nov; 104(9):1235-40. PubMed ID: 19840568
[TBL] [Abstract][Full Text] [Related]
19. A study comparing the incidence and predictors of creatine kinase MB and troponin T release after coronary angioplasty. Does Clopidogrel preloading reduce myocardial necrosis following elective percutaneous coronary intervention?
Moore RK; Lowe R; Grayson AD; Morris JL; Perry RA; Stables RH
Int J Cardiol; 2007 Mar; 116(1):93-7. PubMed ID: 16870281
[TBL] [Abstract][Full Text] [Related]
20. Clopidogrel and percutaneous coronary intervention.
Cannon C
Lancet; 2002 Jan; 359(9301):169. PubMed ID: 11809292
[No Abstract] [Full Text] [Related]
[Next] [New Search]
